This was the first study to systematically investigate the unique transcriptomic profile determined by FGFR3 alterations, and the FGFR3 alteration-related transcriptomic characterization is implicated with biological activities, molecular features, and tumor immune infiltration of BC. The gene discussed is FGFR3; the disease is neoplasm.